[Other antihyperlipidemic drugs with novel mechanism].
Yamashita
S
S
Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University.
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control; D001384:Azetidines / Q000494:pharmacology / Q000627:therapeutic use; D001596:Benzylamines / Q000494:pharmacology / Q000627:therapeutic use; D022762:CCAAT-Enhancer-Binding Proteins / Q000037:antagonists & inhibitors; D002352:Carrier Proteins / Q000037:antagonists & inhibitors*; D002635:Chenodeoxycholic Acid / Q000494:pharmacology / Q000627:therapeutic use; D002784:Cholesterol / Q000096:biosynthesis; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control; D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors; D004164:Diphosphonates / Q000494:pharmacology / Q000627:therapeutic use; D000069438:Ezetimibe; D013186:Farnesyl-Diphosphate Farnesyltransferase / Q000037:antagonists & inhibitors*; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D008095:Lithocholic Acid / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D029363:Organic Anion Transporters, Sodium-Dependent; D010105:Oxygenases / Q000037:antagonists & inhibitors*; D050603:Squalene Monooxygenase; D051780:Sterol Regulatory Element Binding Protein 1; D027981:Symporters; D013876:Thiophenes / Q000494:pharmacology / Q000627:therapeutic use; D014157:Transcription Factors
D001384:Azetidines; D001596:Benzylamines; D022762:CCAAT-Enhancer-Binding Proteins; D002352:Carrier Proteins; D004268:DNA-Binding Proteins; D004164:Diphosphonates; C413901:ER 27856; D000960:Hypolipidemic Agents; D029363:Organic Anion Transporters, Sodium-Dependent; C497387:SREBF1 protein, human; D051780:Sterol Regulatory Element Binding Protein 1; D027981:Symporters; D013876:Thiophenes; D014157:Transcription Factors; D002635:Chenodeoxycholic Acid; C066059:NB 598; C066327:BRL 39924A; C071908:sodium-bile acid cotransporter; D008095:Lithocholic Acid; D002784:Cholesterol; D010105:Oxygenases; D050603:Squalene Monooxygenase; D013186:Farnesyl-Diphosphate Farnesyltransferase; D000069438:Ezetimibe